Breaking Down Fujian Tianma Science and Technology Group Co., Ltd Financial Health: Key Insights for Investors

Peel back the balance sheet of Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) with a close look at headline figures that matter to investors: annual revenue of CNY 5.85 billion (quarterly CNY 1.48 billion) against a cost of revenue of CNY 5.23 billion yields a gross profit of CNY 628.25 million even as annual revenue growth sits at a contraction of -16.34%; on the bottom line TTM net income is a modest CNY 27.40 million (EPS CNY 0.05) while profitability metrics show EBITDA of CNY 485.52 million and an ROE of 0.95%-but capital structure and liquidity raise flags with total debt of CNY 4.63 billion, total equity of CNY 2.88 billion and a debt-to-equity ratio of 160.75% alongside a negative net cash position of CNY 4.09 billion, a current ratio of 0.91, quick ratio 0.21 and negative working capital of CNY 509.50 million; valuation multiples (P/E 319.13, P/S 1.42, P/B 2.88, EV/EBITDA 24.76) and an EV of CNY 12.95 billion frame market expectations, while operationally the firm produced roughly 3,210.26 tons of eel from January-March 2025 with selling prices between CNY 50,000-87,000/ton and operating cash flow of CNY 478.91 million offering potential upside-read on to unpack risks like thin margins and interest coverage of 1.25x against growth levers in aquaculture expansion, premium feed strategies and export opportunities

Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) - Revenue Analysis

• Annual revenue growth: -16.34% (y/y)
• Quarterly revenue growth: -1.21% (q/q)
• Gross profit growth: +23.87% annually and +36.33% quarterly

• Low estimate: 3,210.26 t × CNY 50,000/t = CNY 160,513,000
• High estimate: 3,210.26 t × CNY 87,000/t = CNY 279,297,~ (CNY 279,293,~ rounding)

• High cost of revenue relative to sales (annual cost/revenue ≈ 89.4%)
• Improving gross profit despite revenue decline, indicating cost control or product mix improvement
• Eel production as a material revenue stream with high per-ton pricing supporting gross margin expansion

Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) Profitability Metrics

• Net income (TTM): CNY 27.40 million
• Earnings per share (EPS): CNY 0.05
• EBITDA: CNY 485.52 million
• EBIT: CNY 209.14 million
• Net profit margin: 0.44%
• Return on equity (ROE): 0.95%

Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) - Debt vs. Equity Structure

• Total debt: CNY 4.63 billion
• Total equity: CNY 2.88 billion
• Debt-to-equity ratio: 160.75%
• Interest coverage ratio: 1.25x
• Net cash position: negative CNY 4.09 billion
• Market capitalization: CNY 8.74 billion

• Credit risk: Elevated-interest coverage at 1.25x leaves little buffer against earnings declines.
• Liquidity risk: Negative net cash of CNY 4.09 billion indicates reliance on refinancing or operating cash flow to meet obligations.
• Equity dilution risk: High debt may force equity issuance under stress, diluting existing shareholders.
• Valuation context: Market cap of CNY 8.74 billion relative to net debt suggests enterprise value materially exceeds equity value.

Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) - Liquidity and Solvency

• Current ratio: 0.91
• Quick ratio: 0.21
• Working capital: -CNY 509.50 million
• Cash and cash equivalents: CNY 544.15 million
• Operating cash flow: CNY 478.91 million
• Free cash flow: CNY 93.09 million

Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) - Valuation Analysis

• Current market multiples indicate a high-growth expectation priced into the stock, with notable divergence between earnings-based and sales/book-based metrics.
• Elevated earnings multiple suggests recent earnings are depressed relative to market capitalization or investors anticipate material earnings recovery.
• Enterprise-value multiples (EV/EBITDA, EV/FCF) point to stretched valuation versus cash-generation today.

• Comparative lens: P/S of 1.42 and P/B of 2.88 are less extreme than the P/E and EV/FCF, suggesting top-line and asset values partially justify market cap while profitability and cash conversion currently lag.
• Investors should reconcile the 319.13 P/E with the company's trailing and forward EPS drivers-one-off items, margin recovery, and R&D/capex phasing can materially swing multiples.
• High EV/FCF (139.15) raises sensitivity to small changes in free cash flow; stress-test scenarios for cash conversion are essential for valuation robustness.

Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) - Risk Factors

Fujian Tianma Science and Technology Group faces multiple material risks that can affect solvency, liquidity and investor returns. Below are the principal risk drivers supported by current financial indicators and trend data.

• High leverage: debt-to-equity ratio indicates elevated financial risk and greater sensitivity to revenue shocks.
• Negative net cash: limited liquidity buffer increases dependence on external financing and refinancing risk.
• Falling earnings: a steep decline in profitability growth reduces internal cash generation capacity.
• Low interest coverage: ability to service interest is constrained, raising default risk if earnings weaken further.
• Negative working capital: short-term obligations may exceed short-term assets, pressuring day-to-day operations.
• Competitive, low-margin market: pricing pressure and thin operating margins limit margin recovery in downturns.

Investor considerations driven by these metrics:

• Refinancing risk: with negative net cash and high leverage, access to capital markets or bank credit is critical; any tightening raises solvency concerns.
• Earnings volatility: a -32.87% annual earnings decline implies weaker free cash flow generation and makes dividend sustainability less certain.
• Interest burden: 1.25x coverage leaves limited margin for adverse earnings swings - interest rate rises or one-off charges could push coverage below 1.0x.
• Operational strain from negative working capital and thin margins may force asset sales, cost cuts, or higher short-term borrowing.
• Competitive pressures: low operating margin (~3.5%) makes margin improvement difficult without structural change (product mix, cost base, scale).

For strategic context on the company's stated direction and values, see: Mission Statement, Vision, & Core Values (2026) of Fujian Tianma Science and Technology Group Co., Ltd.

Fujian Tianma Science and Technology Group Co., Ltd (603668.SS) - Growth Opportunities

Fujian Tianma is positioned to capture market upside from both domestic and international demand curves in aquaculture and value-added eel products. Key quantitative indicators and strategic levers underpinning near-term growth include production scale, cash-generation improvement, product-focus differentiation, and capacity investments.

• Strong consumer demand for grilled eel products driving downstream sales growth and higher-margin product mix.
• Expansion potential within China's aquaculture industry as consumption per-capita and premiumization trends continue.
• Increased export opportunities supported by cumulative eel production of approximately 3,210.26 tons in Jan-Mar 2025, enabling higher volumes available for overseas channels.
• Focus on premium, species-specific feed solutions to strengthen gross margin via product differentiation and customer lock-in.
• Targeted investment to maintain or expand production capacity-reducing unit costs and supporting larger-scale contract manufacturing or branded sales.
• Potential for improved profitability supported by stronger operating cash flow of CNY 478.91 million (period referenced), which can fund capex, working capital, or margin-enhancing initiatives.

Operational and market initiatives that investors should track include:

• Realized export volumes and pricing for eel products following the Jan-Mar 2025 production ramp.
• Gross margin trends for premium feed and processed eel product lines (indicates successful premiumization).
• Capex deployment and timeline for any announced capacity expansions funded by improved operating cash flow.
• Working capital conversion and free cash flow trends after reinvestment to assess sustainable profitability improvements.
• Market-share movement in core domestic provinces and entry progress into targeted export markets.

For related corporate direction and values that may influence strategic execution, see: Mission Statement, Vision, & Core Values (2026) of Fujian Tianma Science and Technology Group Co., Ltd.